Telehealth providers in Colorado
By the PeptideAgent Editorial Team. Editorially reviewed, not clinically reviewed. Last verified
Telehealth prescribing is allowed in Colorado, including asynchronous care. What Colorado requires of telehealth prescribers and pharmacies, plus listings with their verification status.
Colorado at a glance
- 503A framework
- Follows the federal 503A framework
- Telehealth prescribing
- Regulatory: Telehealth allowed
- Asynchronous prescribing
- Regulatory: Async allowed
- Compounded GLP-1 access
- Regulatory: Compounded GLP-1 limited
Telehealth providers serving Colorado
Prescription peptides through an online assessment and a licensed provider review, shipped from a licensed U.S. compounding pharmacy.
Telehealth provider · 17 products · partner lists from $172 a month · Says it serves Colorado (not yet confirmed)
- Prescription only, no research-use-only sales
- Public cancellation and refund policy
We may earn a commission from these links.
Telehealth prescribing rules in Colorado
C.R.S. 12-240-107 lists the delivery of telemedicine as the practice of medicine, and C.R.S. 12-240-104(6) defines telemedicine as the delivery of medical services through HIPAA-compliant technologies including store-and-forward transfers. Colorado Medical Board Policy 40-27 says the practice of medicine occurs where the patient is located. A prescriber needs a Colorado license (the Interstate Medical Licensure Compact is one route) or, since January 1, 2026, an out-of-state telehealth registration under C.R.S. 12-30-124; a registered provider may not prescribe controlled substances. The Board's published policies (compilation dated May 2026) are guidance, not rules. Policy 40-03 (revised 2015) says a provider-patient relationship is established when the provider agrees to diagnose and treat and the patient agrees to be treated, whether or not there has been an in-person encounter, once the provider verifies the patient's identity and location, discloses the provider's identity and credentials, and obtains informed consent. Policy 40-27 (issued 2015, revised December 18, 2020 and August 19, 2021) defines telehealth to include store-and-forward transfers, says provider-patient relationships may be established using telehealth technologies in conformance with generally accepted standards of practice, calls for an appropriate medical evaluation and review of relevant clinical history before any prescription, and states that treatment, including a prescription, based solely on an online questionnaire does not constitute an acceptable standard of care. The policy says it does not itself set a standard of care. This record classifies asynchronous prescribing as allowed because both the Medical Practice Act definition and Board Policy 40-27 include store-and-forward transfers in telemedicine and the policy lets the relationship be established through telehealth technologies without requiring a real-time visit. A questionnaire-only intake does not qualify. [2] [3] [4] [5] [6] [16]
Compounded GLP-1 access in Colorado
Colorado patients using a telehealth GLP-1 program should confirm the prescriber holds a Colorado license or an out-of-state telehealth registration and that an out-of-state dispensing pharmacy appears as a registered nonresident prescription drug outlet. The Board of Pharmacy rules (3 CCR 719-1) contain no GLP-1-specific provision, and a 2026 bill to regulate the marketing and distribution of compounded GLP-1 weight-loss medication (SB26-066) was postponed indefinitely in a House committee on May 5, 2026 and did not become law, so federal compounding limits and the general Colorado rules apply. [6] [7] [9] [10] [13] [14]
Research use only sellers in Colorado
Only registered prescription drug outlets, including registered nonresident outlets, may dispense prescription drugs to Colorado patients. "Research use only" peptides sold for human injection are unapproved new drugs under federal law regardless of labeling and are not dispensed by a pharmacist. Colorado law also bars the sale directly: C.R.S. 12-280-131 says no person shall sell, deliver, offer for sale, hold for sale, or give away any new drug not authorized to move in interstate commerce under federal law, with an exception only for drugs intended solely for investigational use by qualified experts and plainly labeled for investigational use only. [7] [8] [15]
How to check a telehealth provider in Colorado
- Confirm the prescriber is licensed or registered to treat patients located in Colorado; the telehealth rules above explain what Colorado requires. [2] [3] [4] [5] [6] [16]
- Ask which pharmacy will fill the prescription and check it in the Colorado State Board of Pharmacy (Division of Professions and Occupations) license lookup. [1] [7] [9] [11] [12]
- Get the full price in writing first: consult fees, membership fees, and the medication itself.
- Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Colorado. [7] [8] [15]
Common questions in Colorado
Can a telehealth provider prescribe me a GLP-1 in Colorado without an in-person visit?
Yes, if the provider holds a Colorado license or a Colorado out-of-state telehealth registration and establishes a provider-patient relationship that meets generally accepted standards of practice. Colorado law lists the delivery of telemedicine as the practice of medicine, and Colorado law defines telemedicine to include store-and-forward transfers (C.R.S. 12-240-104(6)), and the Colorado Medical Board's telehealth policies, which are guidance, say the relationship may be formed through telehealth with appropriate informed consent. The policies do not require a real-time visit, but they say a prescription based solely on an online questionnaire is not acceptable care. [3] [4] [5] [6]
What does an out-of-state pharmacy need to ship compounded peptides to Colorado?
Registration as a nonresident prescription drug outlet with the Colorado State Board of Pharmacy under C.R.S. 12-280-133. The outlet must submit a recent inspection report from its home-state board or a national pharmacy verification program, keep its home-state license valid, and ship compounded drugs into Colorado only on patient-specific prescriptions, so check the Division of Professions and Occupations license lookup before ordering. [1] [7] [9]
Sources
- [1]Colorado State Board of Pharmacy, Division of Professions and Occupations
- [2]Colorado Medical Board, Division of Professions and Occupations
- [3]Colorado Medical Board Policies, compilation dated May 2026 (Policy 40-03 provider-patient relationship; Policy 40-27 telehealth guidelines, revised August 19, 2021), linked from the Board homepage, accessed 2026-09-30
- [4]C.R.S. 12-240-107, Practice of medicine defined (includes telemedicine)
- [5]C.R.S. 12-240-104, Definitions (subsection (6), telemedicine includes store-and-forward transfers), accessed 2026-09-30
- [6]C.R.S. 12-30-124, telehealth by providers with an out-of-state credential who register with a Colorado regulator (added by SB 24-141; Justia 2025 edition), accessed 2026-09-30
- [7]C.R.S. 12-280-133, Nonresident prescription drug outlet, registration, accessed 2026-09-22
- [8]C.R.S. 12-280-131, New drugs, when sales permissible, accessed 2026-09-22
- [9]Colorado Secretary of State, Code of Colorado Regulations 3 CCR 719-1, State Board of Pharmacy Rules (current version effective August 21, 2026; Rules 5.00.15, 21.00.00, 21.20.00), accessed 2026-09-22
- [10]Colorado General Assembly: SB26-066, Regulation of Compounded Weight-Loss Medication (postponed indefinitely May 5, 2026), accessed 2026-09-22